Suppr超能文献

接受静脉-静脉体外膜肺氧合治疗的重症急性肺衰竭成年患者的长期生存情况

Long-Term Survival in Adult Patients With Severe Acute Lung Failure Receiving Veno-Venous Extracorporeal Membrane Oxygenation.

作者信息

Enger Tone Bull, Philipp Alois, Lubnow Matthias, Fischer Marcus, Camboni Daniele, Lunz Dirk, Bein Thomas, Müller Thomas

机构信息

1Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway. 2Department of Cardiothoracic Surgery, University Hospital Regensburg, Regensburg, Germany. 3Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany. 4Department of Anesthesiology, University Hospital Regensburg, Regensburg, Germany.

出版信息

Crit Care Med. 2017 Oct;45(10):1718-1725. doi: 10.1097/CCM.0000000000002644.

Abstract

OBJECTIVES

To assess long-term survival in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation and explore risk factors for long-term mortality.

DESIGN

Single-center prospective cohort study.

SETTING

University Hospital Regensburg, Germany.

PATIENTS

All primary cases supported with veno-venous extracorporeal membrane oxygenation from 2007 to 2016 (n = 553).

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Patients were followed until January 2017. Long-term survival and predictors of long-term mortality were assessed using Kaplan-Meier survival analyses and Cox proportional hazards modeling, respectively. Two hundred eighty-six patients (52%) died during follow-up (mean follow-up 4.8 yr). Two hundred seventeen patients (39%) died during hospitalization, whereas another 69 patients (12%) died during later follow-up. Among hospital survivors, the 1-month, 3-month, 1-year, and 5-year survival rates were 99%, 95%, 86%, and 76%, respectively. Higher age, immunocompromised status, and higher Sequential Organ Failure Assessment scores were associated with long-term mortality, whereas patients with out-of-center cannulation showed improved long-term survival. Due to nonproportional hazards over time, the analysis was repeated for hospital survivors only (n = 336). Only age and immunocompromised state remained significant predictors of late mortality among hospital survivors. Lower Glasgow Outcome Scale at hospital discharge and the University Hospital Regensburg pre-extracorporeal membrane oxygenation score for predicting hospital mortality in veno-venous extracorporeal membrane oxygenation patients before extracorporeal membrane oxygenation initiation were associated with late mortality in hospital survivors (p < 0.001).

CONCLUSIONS

Whereas acute illness factors may be important in prediction of hospital outcomes in veno-venous extracorporeal membrane oxygenation patients, they do not determine late mortality in hospital survivors. Preexisting morbidity and functional ability at hospital discharge may be important determinants of long-term survival in veno-venous extracorporeal membrane oxygenation patients.

摘要

目的

评估接受静脉-静脉体外膜肺氧合的成年重症急性肺衰竭患者的长期生存率,并探讨长期死亡的危险因素。

设计

单中心前瞻性队列研究。

地点

德国雷根斯堡大学医院。

患者

2007年至2016年期间接受静脉-静脉体外膜肺氧合支持的所有原发病例(n = 553)。

干预措施

无。

测量指标及主要结果

对患者进行随访至2017年1月。分别采用Kaplan-Meier生存分析和Cox比例风险模型评估长期生存率和长期死亡的预测因素。286例患者(52%)在随访期间死亡(平均随访4.8年)。217例患者(39%)在住院期间死亡,另有69例患者(12%)在后期随访中死亡。在住院幸存者中,1个月、3个月、1年和5年生存率分别为99%、95%、86%和76%。年龄较大、免疫功能低下状态以及较高的序贯器官衰竭评估评分与长期死亡相关,而采用外周插管的患者长期生存率有所提高。由于随时间存在非比例风险,仅对住院幸存者(n = 336)重复进行分析。在住院幸存者中,只有年龄和免疫功能低下状态仍然是晚期死亡的显著预测因素。出院时较低的格拉斯哥预后评分以及雷根斯堡大学医院在开始体外膜肺氧合之前用于预测静脉-静脉体外膜肺氧合患者医院死亡率的体外膜肺氧合前评分与住院幸存者的晚期死亡相关(p < 0.001)。

结论

虽然急性疾病因素在预测静脉-静脉体外膜肺氧合患者的医院结局方面可能很重要,但它们并不能决定住院幸存者的晚期死亡。出院时已存在的发病率和功能能力可能是静脉-静脉体外膜肺氧合患者长期生存的重要决定因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验